Entrada Therapeutics, Inc. (TRDA)
13.99
+0.43
(+3.17%)
USD |
NASDAQ |
Apr 17, 16:00
14.27
+0.28
(+2.00%)
Pre-Market: 20:00
Entrada Therapeutics SG&A Expense (Quarterly) : 9.55M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Tyra Biosciences, Inc. | 8.33M |
| Biogen, Inc. | 682.50M |
| EyePoint, Inc. | 11.38M |
| Vertex Pharmaceuticals, Inc. | 487.00M |
| Arcutis Biotherapeutics, Inc. | 78.98M |